We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXP icon
1451
LXP Industrial Trust
LXP
$3.57B
$125K ﹤0.01%
2,796
+2,613
+1,428% +$112K
IONQ icon
1452
IonQ
IONQ
$15.6B
$125K ﹤0.01%
2,032
+1,323
+187% +$62.2K
ARQT icon
1453
Arcutis Biotherapeutics
ARQT
$3.26B
$125K ﹤0.01%
6,627
+6,008
+971% +$94.8K
APG icon
1454
APi Group
APG
$18B
$125K ﹤0.01%
3,633
+2,089
+135% +$72.9K
HOMB icon
1455
Home BancShares
HOMB
$6.3B
$125K ﹤0.01%
4,407
+314
+8% +$9.12K
XHR
1456
Xenia Hotels & Resorts
XHR
$1.89B
$124K ﹤0.01%
9,067
+8,579
+1,758% +$117K
PVH icon
1457
PVH
PVH
$4.09B
$124K ﹤0.01%
+1,484
New +$117K
SBH icon
1458
Sally Beauty Holdings
SBH
$1.58B
$124K ﹤0.01%
7,602
+7,360
+3,041% +$92.5K
MATX icon
1459
Matsons
MATX
$6.46B
$123K ﹤0.01%
+1,249
New +$134K
UGI icon
1460
UGI
UGI
$7.77B
$122K ﹤0.01%
3,681
+1,080
+42% +$37.8K
AHR icon
1461
American Healthcare REIT
AHR
$10.5B
$122K ﹤0.01%
2,912
+2,124
+270% +$85.4K
JBSS icon
1462
John B. Sanfilippo & Son
JBSS
$986M
$122K ﹤0.01%
1,901
+1,765
+1,298% +$114K
HPP
1463
Hudson Pacific Properties
HPP
$758M
$122K ﹤0.01%
+6,303
New +$119K
RYZ
1464
Ryerson Holding Corp
RYZ
$1.4B
$121K ﹤0.01%
+5,310
New +$119K
JPC icon
1465
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
$121K ﹤0.01%
14,722
-871
-6% -$7.06K
HBCP icon
1466
Home Bancorp
HBCP
$571M
$121K ﹤0.01%
+2,220
New +$122K
PCYO icon
1467
Pure Cycle
PCYO
$255M
$120K ﹤0.01%
10,883
+7,536
+225% +$78.8K
NRC icon
1468
NRC Health Common Stock
NRC
$434M
$120K ﹤0.01%
9,406
+8,910
+1,796% +$134K
FVAL icon
1469
Fidelity Value Factor ETF
FVAL
$1.37B
$120K ﹤0.01%
1,744
+1,700
+3,864% +$113K
SBCF icon
1470
Seacoast Banking Corp of Florida
SBCF
$3.43B
$120K ﹤0.01%
3,934
+3,908
+15,031% +$116K
FSUN
1471
FirstSun Capital Bancorp
FSUN
$1.96B
$120K ﹤0.01%
+3,081
New +$116K
LNT icon
1472
Alliant Energy
LNT
$18.3B
$119K ﹤0.01%
1,769
+1,708
+2,800% +$110K
SIG icon
1473
Signet Jewelers
SIG
$3.78B
$119K ﹤0.01%
1,243
+1,238
+24,760% +$106K
MXL icon
1474
MaxLinear
MXL
$6.6B
$119K ﹤0.01%
7,408
+7,011
+1,766% +$110K
TTI icon
1475
TETRA Technologies
TTI
$1.28B
$119K ﹤0.01%
+20,687
New +$88.3K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.